The advisory panel of the FDA today, Oct. 27, voted unanimously to expand COVID-19 vaccinations for children, 5 to 11. There was on abstention.
They endorsed the Pfizer vaccine saying benefits outweigh any potential risks.
The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as government advisers on Tuesday endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds. https://t.co/RYdBZLOKGn
— CBS 13 News (@WGME) October 27, 2021
Boston doctors weigh the risks and benefits of COVID-19 vaccinations for 5- to 11-year-olds amid a lack of data on the rate of myocarditis, a rare but serious side effect. https://t.co/nWFtd0AyHs
— NECN (@NECN) October 27, 2021